Beranda › Resistensi Insulin › California
Uji klinis Resistensi Insulin di California
11 studi untuk Resistensi Insulin mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
- UCSF Medical Center at Parnassus, San Francisco
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07087184Type 1 Diabetes Extension Study
- UCSF School of Medicine, San Francisco
- Stanford University, Stanford
Menerima pesertaStudi observasional
Usia 8 hingga 35 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT02734277INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Children's Hospital Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
Menerima pesertaFase 2
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07224321DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- Cedars Sinai Medical Center, Los Angeles
- University of California San Francisco, San Francisco
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 25 Jun 2026 · NCT06445946Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
Menerima pesertaFase 2
Usia 21 hingga 85 · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT04984226A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- ProSciento, Inc., Chula Vista
Menerima pesertaFase 1
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT07341373Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Loma Linda University Cancer Center, Loma Linda
- Hoag Memorial Hospital Presbyterian, Newport
- SHARP Healthcare, San Diego
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Apr 2026 · NCT05455619Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Stanford University, Palo Alto
- Stanford University, Clinical and Translational Research Unit (CTRU), Stanford
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 30 hingga 70 · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT06657209Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- San Francisco Research Institute, San Francisco
Menerima pesertaSukarelawan sehat diterima
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT07220694Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Stanford Health, Palo Alto
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 4 Des 2024 · NCT05833217Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
Menerima pesertaSukarelawan sehat diterima
Usia 35 hingga 65 · Semua jenis kelamin · Diperbarui 4 Des 2024 · NCT05165706Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.